Prevalence of Hepatitis D Virus Infection Among Hepatitis B Virus Infected Patients in Qom Province, Center of Iran

Background Hepatitis D virus (HDV) is a defective RNA virus that depends on the hepatitis B surface antigen (HBsAg) of hepatitis B virus for its replication, developing exclusively in patients with acute or chronic hepatitis B. There are little data regarding the routes of HDV transmission in Iran. The risk factors for HDV infection in Iran are blood transfusion, surgery, family history, Hejamat wet cupping (traditional phlebotomy), tattooing, war injury, dental interventions, and endoscopy. Objectives We performed this study to determine the prevalence of hepatitis D in the general population of Qom province and the potential risk factors for acquiring HDV. Patients and Methods This cross-sectional study collected 3690 samples from 7 rural clusters and 116 urban clusters. HBs antigen was measured, and if the test was positive, anti-HDV was measured. Ten teams, each consisting of 2 trained members, were assigned to conduct the sampling and administer the questionnaires. The data were analyzed using SPSS. Results Forty-eight subjects (1.3%) suffered from hepatitis B, and 1 HBsAg-positive case had HDV infection. The prevalence of hepatitis D infection in Qom Province was 0.03%. The prevalence of hepatitis D infection in HBsAg-positive cases was 2%. Our anti-HDV-positive case had a history of tattooing, surgery, and dental surgery. There was no significant relationship between tattooing, surgery history, or dental surgery and hepatitis D infection. Conclusions The prevalence of hepatitis D in Qom is the the lowest in Iran, similar to a study in Babol (north of Iran).

[1]  K. Azimi,et al.  Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors , 2012 .

[2]  S. Alavian We Have More Data Regarding Epidemiology of Hepatitis D in Iran but There are Defects to be Filled Yet , 2008 .

[3]  S. Vaziri,et al.  HEPATITIS D VIRUS INFECTION AMONG HIV-HBV CO-INFECTED PATIENTS IN KERMANSHAH, WEST OF IRAN , 2008 .

[4]  D. Mehrbani,et al.  HEPATITIS D IN CHRONIC ACTIVE HEPATITIS B: PREVALENCE, LIVER ENZYME LEVELS AND HISTOPATHOLOGY-AN EPIDEMIOLOGICAL STUDY IN SHIRAZ, SOUTHERN IRAN, 2003-2004 , 2008 .

[5]  G. Roshandel,et al.  Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. , 2008, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  S. Alavian,et al.  The changing epidemiology of viral hepatitis B in Iran. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[7]  G. Roshandel,et al.  Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. , 2007, Pakistan journal of biological sciences : PJBS.

[8]  Joshaghani Hamidreza,et al.  Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. , 2007, Indian journal of medical sciences.

[9]  S. Alavian,et al.  Is War Injury a Risk Factor of Hepatitis D in Hepatitis B Patients , 2005 .

[10]  S. Alavian,et al.  FREQUENCY AND RISK FACTORS OF HEPATITIS D VIRUS IN HEPATITIS B PATIENTS , 2005 .

[11]  B. Forouzandeh,et al.  A study on delta virus infection and its clinical impact in Iran , 2005, Infection.

[12]  G. Darmstadt,et al.  Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. , 2003, Journal of tropical pediatrics.

[13]  S. Ebrahimpour,et al.  SEROEPIDEMIOLOGICAL STUDIES OF HEPATITIS DELTA (HDV) IN HBSAG POSITIVE INDIVIDUALS IN TABRIZ , 2003 .

[14]  E. Sagnelli,et al.  Chronic hepatitis D: A vanishing disease? An Italian multicenter study , 2000, Hepatology.

[15]  A. Amirkhani,et al.  INVESTIGATION AND COMPARISON OF HEPATITIS D PREVALENCE IN DIALYSIS PATIENTS AND THE DONORS OF HBSAG CARRIER , 2000 .

[16]  Grudinin Mp,et al.  The frequency of antibodies against delta virus in patients with HBs positive hepatitis , 1996 .

[17]  M. Grudinin,et al.  [The frequency of antibodies against delta virus in patients with HBs positive hepatitis]. , 1996, Voprosy virusologii.

[18]  J. de Miguel,et al.  [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus]. , 1994, Revista clinica espanola.

[19]  S. Amini,et al.  Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. , 1993, The Journal of tropical medicine and hygiene.

[20]  F. Olesen,et al.  [Extrapyramidal side effects after long-term treatment with thiethylperazine]. , 1988 .

[21]  F. Olesen,et al.  [Depression as a side effect of treatment with flunarizine?]. , 1988, Ugeskrift for laeger.

[22]  L. Theilmann,et al.  Prevalence of the hepatitis delta virus in Rumania. , 1986, Hepato-gastroenterology.

[23]  D. Brettler,et al.  Epidemiology and clinical impact of hepatitis D virus (delta) infection , 1985, Hepatology.

[24]  R. Belshe Textbook of human virology , 1984 .